04/01/2024
3:37 PM | Alnylam Pharmaceuticals (Filer)
| Form ARS | |
04/01/2024
3:31 PM | Alnylam Pharmaceuticals (Filer)
| Form DEF 14A | |
03/04/2024
3:33 PM | Alnylam Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
3:16 PM | Alnylam Pharmaceuticals (Issuer)
Franchini Indrani Lall (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:17 PM | Alnylam Pharmaceuticals (Issuer)
Garg Pushkal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:18 PM | Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:18 PM | Alnylam Pharmaceuticals (Issuer)
Poulton Jeffrey V. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
02/29/2024
3:18 PM | Alnylam Pharmaceuticals (Issuer)
Tanguler Tolga (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:00 PM | Alnylam Pharmaceuticals (Subject)
SHARP PHILLIP A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/15/2024
7:10 AM | Alnylam Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/09/2024
7:35 AM | Alnylam Pharmaceuticals (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
02/09/2024
7:40 AM | Alnylam Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
02/05/2024
3:05 PM | Alnylam Pharmaceuticals (Issuer)
Franchini Indrani Lall (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
11:18 AM | Alnylam Pharmaceuticals (Subject)
BAILLIE GIFFORD & CO (Filed by)
| Form SC 13G/A | |
01/19/2024
3:31 PM | Alnylam Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
6:00 AM | Alnylam Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
7:10 AM | Alnylam Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
7:22 AM | Alnylam Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/10/2023
6:30 AM | Alnylam Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2023
6:30 AM | Alnylam Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/28/2023
4:00 PM | Alnylam Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2023
5:04 PM | Alnylam Pharmaceuticals (Issuer)
Vaishnaw Akshay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2023
5:04 PM | Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2023
5:05 PM | Alnylam Pharmaceuticals (Issuer)
Poulton Jeffrey V. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2023
5:05 PM | Alnylam Pharmaceuticals (Issuer)
Garg Pushkal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2023
7:10 AM | Alnylam Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
7:18 AM | Alnylam Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/30/2023
8:03 AM | Alnylam Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/23/2023
3:30 PM | Alnylam Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/04/2023
7:22 AM | Alnylam Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/04/2023
7:10 AM | Alnylam Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/28/2023
4:54 PM | Alnylam Pharmaceuticals (Issuer)
Garg Pushkal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/28/2023
4:54 PM | Alnylam Pharmaceuticals (Issuer)
Vaishnaw Akshay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/28/2023
4:55 PM | Alnylam Pharmaceuticals (Issuer)
Tanguler Tolga (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/28/2023
4:55 PM | Alnylam Pharmaceuticals (Issuer)
Poulton Jeffrey V. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/28/2023
4:55 PM | Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/28/2023
12:25 PM | Alnylam Pharmaceuticals (Subject)
Garg Pushkal (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
